logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jung Yong Hong

Sungkyunkwan University School of Medicine
H指数:32
被引数:4,283

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: Phase IIIb single-arm SIERRA study

一线度伐利尤单抗和特瑞普利单抗在预后不良的不可切除肝细胞癌中的应用：IIIb期单臂SIERRA研究

Journal of Hepatology
IF33
2026-10-060
OAAI
Stephen L. Chan; Masatoshi Kudo; Bruno Sangro; Robin Kate Kelley; Jee Hyun Kim; Binh Pham; Jung Yong Hong; Dirk-Thomas Waldschmidt; Donatella Marino; René Gerolami; Adam M. Burgoyne; Gianluca Masi; Robert John Walsh; Jens U. Marquardt; Ugochinyere Emeribe; Kavitha Balaji; Peng Sun; Boris Baur; Lorenza Rimassa
Tailored proton beam therapy for hepatocellular carcinoma: Addressing unmet needs through a multidisciplinary approach

针对肝细胞癌的定制化质子束疗法：通过多学科方法解决未满足的需求

European Journal of Cancer
IF7.1
2026-02-180
PRE
Jeong Ha Lee; Nalee Kim; Jeong Il Yu; Hee Chul Park; Sungkoo Cho; Byeong Geun Song; Myung Ji Goh; Wonseok Kang; Dong Hyun Sinn; Geum-Youn Gwak; Joon Hyeok Lee; Yong-Han Paik; Moon Seok Choi; Minsuk Kwon; Jung Yong Hong; Gyu-Seong Choi; Woo Kyoung Jeong; Min Woo Lee; Dong-Ho Hyun; Sang Yun Ha
Differential implications of tumor endothelial cell and lymphocyte densities in advanced hepatocellular carcinoma patients treated with immunotherapy

肿瘤内皮细胞和淋巴细胞密度在免疫治疗治疗的晚期肝细胞癌患者中的差异意义

npj Precision Oncology
IF8
2025-12-110
OAAI
Gwangil Kim; Beodeul Kang; Jung Yong Hong; Haeyoun Kang; Jung Sun Kim; Sohyun Hwang; Sung Hwan Lee; Sang Hoon Jung; Chansik An; Won Suk Lee; Chiyoon Oum; Gahee Park; Mingu Kang; Yoojoo Lim; Jin Woo Oh; Siraj M. Ali; Chan-Young Ock; Chan Kim; Ho Yeong Lim; Hong Jae Chon
Early Safety Results from the Phase 3b SIERRA Study of Durvalumab and Tremelimumab as First-Line Treatment for Participants with Unresectable Hepatocellular Carcinoma and a Poor Prognosis

IIIb期SIERRA研究早期安全性结果：度伐利尤单抗和特瑞普利单抗作为不可切除肝细胞癌且预后不良患者的一线治疗方案。

Liver Cancer
IF9.1
2025-12-010
OA
Chan, Stephen Lam; Kudo, Masatoshi; Sangro, Bruno; Kelley, Robin Kate; Kim, Jee Hyun; Pham, Binh; Hong, Jung Yong; Waldschmidt, Dirk-Thomas; Marino, Donatella; Lee, Jie Xin Joycelyn; Gerolami, Rene; Burgoyne, Adam M.; Li, Qiao; Nakamura, Hitomi; Sun, Peng; Baur, Boris; Rimassa, Lorenza
Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter Study

Lenvatinib和Sorafenib作为肝细胞癌一线治疗的真实世界比较：一项多中心研究

Journal of Hepatocellular Carcinoma
IF3.4
2025-11-250
OAAI
Mira Kang; Won Chul Cha; Dong Hyun Sinn; Woo Kyoung Jeong; Do Young Kim; Min Ji Lee; Subin Lim; DongKyu Kim; Kyu-Pyo Kim; Baek-Yeol Ryoo; Won-Mook Choi; Kang Mo Kim; Ki-Hun Kim; Doik Lee; Eui Jun Choi; Choungwon Jung; Joohyun Kim; Jung Yong Hong
First-in-human study of ABBV-969, a dual variable antibody-drug conjugate (ADC), in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

ABBV-969首次人体研究，该药物是一种双变量抗体药物偶联物（ADC），用于治疗转移性去势抵抗性前列腺癌（mCRPC）的患者（pts）。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Berger, R.; Tolcher, A. W.; Dorff, T. B.; Okubo, S.; Abraham, L. S.; Reilly, R.; Stevenson, C.; Wang, S.; Arnold, J.; Mudd, S. R.; Alaei, S.; Hong, J.; Quinn, D. I.; Saad, F.; Powderly, J.
Efficacy and safety of lenvatinib vs sorafenib in hepatocellular carcinoma: A multi-center real-world study from the LINK Research Network

仑伐替尼与索拉非尼在肝细胞癌中的疗效与安全性比较：LINK研究网络的多中心真实世界研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Hong, J. Y.; Kang, M.; Sinn, D. H.; Cha, W. C.; Jeong, W. K.; Kim, D-Y.; Lee, M. J.; Lim, S.; Kim, D.; Kim, K-P.; Ryoo, B-Y.; Choi, W-M.; Kim, K.; Kim, K-H.; Choi, E. J.; Jung, C.; Lee, D.; Kim, J.
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries

亚太国家一线阿特珠单抗联合贝伐单抗治疗肝细胞癌后系统治疗的真实世界研究

LIVER CANCER
IF9.1
2024-08-200
OAAI
Lee, Choong-kun; Yoo, Changhoon; Hong, Jung Yong; Park, Se Jun; Kim, Jin Won; Tai, David Wai Meng; Kim, Hyeyeong; Korphaisarn, Krittiya; Tanasanvimon, Suebpong; Chen, San-Chi; Kim, Ju Won; Kim, Ilhwan; Kim, Moonho; Choo, Joan; Oh, Sang-Bo; Chen, Ching-Tso; Bae, Woo Kyun; Kim, Hongsik; Huh, Seok Jae; Yen, Chia-Jui; Park, Sejung; Lee, Dong Ki; Chan, Landon Long; Kang, Beodeul; Kang, Minsu; Sundar, Raghav; Choi, Hye Jin; Chan, Stephen Lam; Chon, Hong Jae; Lee, Myung-Ah

研究方向

暂未获取到该数据
H
Ho Yeong Lim
H 指数:78论文数:586被引数:3.9万
J
Joon Oh Park
H 指数:74论文数:568被引数:3.0万
W
Won Ki Kang
H 指数:71论文数:637被引数:2.5万
J
Jeeyun Lee
H 指数:78论文数:1,079被引数:3.3万
S
Seung Tae Kim
H 指数:45论文数:523被引数:1.1万
Y
Young Suk Park
H 指数:50论文数:298被引数:1.0万
S
Se Hoon Park
H 指数:72论文数:673被引数:3.0万
J
Joo‐Hyun Park
H 指数:27论文数:206被引数:2,171
C
Cheolwon Suh
H 指数:50论文数:615被引数:1.3万
D
Dok Hyun Yoon
H 指数:44论文数:525被引数:7,345